Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 62

1.

Native versus deglycosylated IgM in anti-MAG neuropathy: Correlation with clinical status - Study of 10 cases.

Neil J, Choumet V, Beadon K, Delmont E, Ghillani P, Boucraut J, Musset L, Léger JM.

J Neuroimmunol. 2020 Feb 15;339:577094. doi: 10.1016/j.jneuroim.2019.577094. Epub 2019 Nov 4.

PMID:
31756640
2.

Midgut barriers prevent the replication and dissemination of the yellow fever vaccine in Aedes aegypti.

Danet L, Beauclair G, Berthet M, Moratorio G, Gracias S, Tangy F, Choumet V, Jouvenet N.

PLoS Negl Trop Dis. 2019 Aug 14;13(8):e0007299. doi: 10.1371/journal.pntd.0007299. eCollection 2019 Aug.

3.

Bioluminescent Ross River Virus Allows Live Monitoring of Acute and Long-Term Alphaviral Infection by In Vivo Imaging.

Belarbi E, Legros V, Basset J, Desprès P, Roques P, Choumet V.

Viruses. 2019 Jun 27;11(7). pii: E584. doi: 10.3390/v11070584.

4.

Infection Kinetics and Tropism of Borrelia burgdorferi sensu lato in Mouse After Natural (via Ticks) or Artificial (Needle) Infection Depends on the Bacterial Strain.

Sertour N, Cotté V, Garnier M, Malandrin L, Ferquel E, Choumet V.

Front Microbiol. 2018 Jul 31;9:1722. doi: 10.3389/fmicb.2018.01722. eCollection 2018.

5.

Infection of a French Population of Aedes albopictus and of Aedes aegypti (Paea Strain) with Zika Virus Reveals Low Transmission Rates to These Vectors' Saliva.

Ryckebusch F, Berthet M, Missé D, Choumet V.

Int J Mol Sci. 2017 Nov 10;18(11). pii: E2384. doi: 10.3390/ijms18112384.

6.

Infection of Ixodes ricinus by Borrelia burgdorferi sensu lato in peri-urban forests of France.

Marchant A, Le Coupanec A, Joly C, Perthame E, Sertour N, Garnier M, Godard V, Ferquel E, Choumet V.

PLoS One. 2017 Aug 28;12(8):e0183543. doi: 10.1371/journal.pone.0183543. eCollection 2017.

7.

Co-Infection of Mosquitoes with Chikungunya and Dengue Viruses Reveals Modulation of the Replication of Both Viruses in Midguts and Salivary Glands of Aedes aegypti Mosquitoes.

Le Coupanec A, Tchankouo-Nguetcheu S, Roux P, Khun H, Huerre M, Morales-Vargas R, Enguehard M, Lavillette D, Missé D, Choumet V.

Int J Mol Sci. 2017 Aug 4;18(8). pii: E1708. doi: 10.3390/ijms18081708.

8.

Imipramine Inhibits Chikungunya Virus Replication in Human Skin Fibroblasts through Interference with Intracellular Cholesterol Trafficking.

Wichit S, Hamel R, Bernard E, Talignani L, Diop F, Ferraris P, Liegeois F, Ekchariyawat P, Luplertlop N, Surasombatpattana P, Thomas F, Merits A, Choumet V, Roques P, Yssel H, Briant L, Missé D.

Sci Rep. 2017 Jun 9;7(1):3145. doi: 10.1038/s41598-017-03316-5.

9.

European Aedes albopictus and Culex pipiens Are Competent Vectors for Japanese Encephalitis Virus.

de Wispelaere M, Desprès P, Choumet V.

PLoS Negl Trop Dis. 2017 Jan 13;11(1):e0005294. doi: 10.1371/journal.pntd.0005294. eCollection 2017 Jan.

10.

The effects of mosquito saliva on dengue virus infectivity in humans.

Wichit S, Ferraris P, Choumet V, Missé D.

Curr Opin Virol. 2016 Dec;21:139-145. doi: 10.1016/j.coviro.2016.10.001. Epub 2016 Oct 19. Review.

PMID:
27770704
11.

Guillain-Barré Syndrome outbreak associated with Zika virus infection in French Polynesia: a case-control study.

Cao-Lormeau VM, Blake A, Mons S, Lastère S, Roche C, Vanhomwegen J, Dub T, Baudouin L, Teissier A, Larre P, Vial AL, Decam C, Choumet V, Halstead SK, Willison HJ, Musset L, Manuguerra JC, Despres P, Fournier E, Mallet HP, Musso D, Fontanet A, Neil J, Ghawché F.

Lancet. 2016 Apr 9;387(10027):1531-1539. doi: 10.1016/S0140-6736(16)00562-6. Epub 2016 Mar 2.

12.

Dengue and other flavivirus infections.

Choumet V, Desprès P.

Rev Sci Tech. 2015 Aug;34(2):473-8, 467-72. Review. English, French.

13.

Biology of Zika Virus Infection in Human Skin Cells.

Hamel R, Dejarnac O, Wichit S, Ekchariyawat P, Neyret A, Luplertlop N, Perera-Lecoin M, Surasombatpattana P, Talignani L, Thomas F, Cao-Lormeau VM, Choumet V, Briant L, Desprès P, Amara A, Yssel H, Missé D.

J Virol. 2015 Sep;89(17):8880-96. doi: 10.1128/JVI.00354-15. Epub 2015 Jun 17.

14.

Inflammasome signaling pathways exert antiviral effect against Chikungunya virus in human dermal fibroblasts.

Ekchariyawat P, Hamel R, Bernard E, Wichit S, Surasombatpattana P, Talignani L, Thomas F, Choumet V, Yssel H, Desprès P, Briant L, Missé D.

Infect Genet Evol. 2015 Jun;32:401-8. doi: 10.1016/j.meegid.2015.03.025. Epub 2015 Apr 4.

PMID:
25847693
15.

Infection of Siberian chipmunks (Tamias sibiricus barberi) with Borrelia sp. reveals a low reservoir competence under experimental conditions.

Bonnet S, Choumet V, Masseglia S, Cote M, Ferquel E, Lilin T, Marsot M, Chapuis JL, Vourc'h G.

Ticks Tick Borne Dis. 2015 Apr;6(3):393-400. doi: 10.1016/j.ttbdis.2015.03.008. Epub 2015 Mar 21.

PMID:
25805623
16.

Incidence and hospitalisation rates of Lyme borreliosis, France, 2004 to 2012.

Vandenesch A, Turbelin C, Couturier E, Arena C, Jaulhac B, Ferquel E, Choumet V, Saugeon C, Coffinieres E, Blanchon T, Vaillant V, Hanslik T.

Euro Surveill. 2014 Aug 28;19(34). pii: 20883.

17.

Role of skin immune cells on the host susceptibility to mosquito-borne viruses.

Briant L, Desprès P, Choumet V, Missé D.

Virology. 2014 Sep;464-465:26-32. doi: 10.1016/j.virol.2014.06.023. Epub 2014 Jul 18. Review.

18.

Comparative population genomics of the Borrelia burgdorferi species complex reveals high degree of genetic isolation among species and underscores benefits and constraints to studying intra-specific epidemiological processes.

Jacquot M, Gonnet M, Ferquel E, Abrial D, Claude A, Gasqui P, Choumet V, Charras-Garrido M, Garnier M, Faure B, Sertour N, Dorr N, De Goër J, Vourc'h G, Bailly X.

PLoS One. 2014 Apr 10;9(4):e94384. doi: 10.1371/journal.pone.0094384. eCollection 2014.

19.

Clone 13-infected Aedes aegypti salivary components inhibit Rift Valley fever virus pathogenicity.

Le Coupanec A, Babin D, Bouloy M, Choumet V.

Microbes Infect. 2014 May;16(5):439-44. doi: 10.1016/j.micinf.2014.01.008. Epub 2014 Feb 13.

PMID:
24530502
20.

Differential expression of Ixodes ricinus salivary gland proteins in the presence of the Borrelia burgdorferi sensu lato complex.

Cotté V, Sabatier L, Schnell G, Carmi-Leroy A, Rousselle JC, Arsène-Ploetze F, Malandrin L, Sertour N, Namane A, Ferquel E, Choumet V.

J Proteomics. 2014 Jan 16;96:29-43. doi: 10.1016/j.jprot.2013.10.033. Epub 2013 Nov 2.

PMID:
24189444
21.

Aedes mosquito saliva modulates Rift Valley fever virus pathogenicity.

Le Coupanec A, Babin D, Fiette L, Jouvion G, Ave P, Misse D, Bouloy M, Choumet V.

PLoS Negl Trop Dis. 2013 Jun 13;7(6):e2237. doi: 10.1371/journal.pntd.0002237. Print 2013.

22.

New markers in Anopheles gambiae salivary glands after Plasmodium berghei infection.

Zocevic A, Carmi-Leroy A, Sautereau J, d'Alayer J, Lenormand P, Rousselle JC, Namane A, Choumet V.

Vector Borne Zoonotic Dis. 2013 Feb;13(2):119-27. doi: 10.1089/vbz.2012.0964. Epub 2013 Jan 5.

PMID:
23289400
23.

Visualizing non infectious and infectious Anopheles gambiae blood feedings in naive and saliva-immunized mice.

Choumet V, Attout T, Chartier L, Khun H, Sautereau J, Robbe-Vincent A, Brey P, Huerre M, Bain O.

PLoS One. 2012;7(12):e50464. doi: 10.1371/journal.pone.0050464. Epub 2012 Dec 13.

24.

Infection by chikungunya virus modulates the expression of several proteins in Aedes aegypti salivary glands.

Tchankouo-Nguetcheu S, Bourguet E, Lenormand P, Rousselle JC, Namane A, Choumet V.

Parasit Vectors. 2012 Nov 15;5:264. doi: 10.1186/1756-3305-5-264.

25.

Update on the proteomics of major arthropod vectors of human and animal pathogens.

Patramool S, Choumet V, Surasombatpattana P, Sabatier L, Thomas F, Thongrungkiat S, Rabilloud T, Boulanger N, Biron DG, Missé D.

Proteomics. 2012 Dec;12(23-24):3510-23. doi: 10.1002/pmic.201200300. Epub 2012 Nov 12. Review.

PMID:
23077092
26.

Guillain-Barre syndrome: first description of a snake envenomation aetiology.

Neil J, Choumet V, Le Coupanec A, d'Alayer J, Demeret S, Musset L.

J Neuroimmunol. 2012 Jan 18;242(1-2):72-7. doi: 10.1016/j.jneuroim.2011.11.007. Epub 2011 Dec 15.

PMID:
22172144
27.

Proteomic analysis of an Aedes albopictus cell line infected with Dengue serotypes 1 and 3 viruses.

Patramool S, Surasombatpattana P, Luplertlop N, Sévéno M, Choumet V, Thomas F, Missé D.

Parasit Vectors. 2011 Jul 18;4:138. doi: 10.1186/1756-3305-4-138.

28.

Differential protein modulation in midguts of Aedes aegypti infected with chikungunya and dengue 2 viruses.

Tchankouo-Nguetcheu S, Khun H, Pincet L, Roux P, Bahut M, Huerre M, Guette C, Choumet V.

PLoS One. 2010 Oct 5;5(10). pii: e13149. doi: 10.1371/journal.pone.0013149.

29.

Reappraisal of Vipera aspis venom neurotoxicity.

Ferquel E, de Haro L, Jan V, Guillemin I, Jourdain S, Teynié A, d'Alayer J, Choumet V.

PLoS One. 2007 Nov 21;2(11):e1194.

30.

Phospholipase A2 diversity and polymorphism in European viper venoms: paradoxical molecular evolution in Viperinae.

Jan VM, Guillemin I, Robbe-Vincent A, Choumet V.

Toxicon. 2007 Dec 15;50(8):1140-61. Epub 2007 Aug 12.

PMID:
17904178
31.

The salivary glands and saliva of Anopheles gambiae as an essential step in the Plasmodium life cycle: a global proteomic study.

Choumet V, Carmi-Leroy A, Laurent C, Lenormand P, Rousselle JC, Namane A, Roth C, Brey PT.

Proteomics. 2007 Sep;7(18):3384-94.

32.

Toxicokinetic and toxicodynamic analyses of Androctonus australis hector venom in rats: optimization of antivenom therapy.

Hammoudi-Triki D, Lefort J, Rougeot C, Robbe-Vincent A, Bon C, Laraba-Djebari F, Choumet V.

Toxicol Appl Pharmacol. 2007 Feb 1;218(3):205-14. Epub 2006 Nov 11.

PMID:
17198719
33.

Gene silencing in mosquito salivary glands by RNAi.

Boisson B, Jacques JC, Choumet V, Martin E, Xu J, Vernick K, Bourgouin C.

FEBS Lett. 2006 Apr 3;580(8):1988-92. Epub 2006 Mar 6.

34.

Molecular phylogeny of Vipera Laurenti, 1768 and the related genera Macrovipera (Reuss, 1927) and Daboia (Gray, 1842), with comments about neurotoxic Vipera aspis aspis populations.

Garrigues T, Dauga C, Ferquel E, Choumet V, Failloux AB.

Mol Phylogenet Evol. 2005 Apr;35(1):35-47. Epub 2005 Jan 20.

PMID:
15737580
35.

Pharmacokinetic studies of scorpion venom before and after antivenom immunotherapy.

Krifi MN, Savin S, Debray M, Bon C, El Ayeb M, Choumet V.

Toxicon. 2005 Feb;45(2):187-98.

PMID:
15626368
36.

Epidemiological data, clinical admission gradation and biological quantification by ELISA of scorpion envenomations in Algeria: effect of immunotherapy.

Hammoudi-Triki D, Ferquel E, Robbe-Vincent A, Bon C, Choumet V, Laraba-Djebari F.

Trans R Soc Trop Med Hyg. 2004 Apr;98(4):240-50.

PMID:
15049463
38.
39.

Unusual neurotoxic envenomations by Vipera aspis aspis snakes in France.

de Haro L, Robbe-Vincent A, Saliou B, Valli M, Bon C, Choumet V.

Hum Exp Toxicol. 2002 Mar;21(3):137-45.

PMID:
12102539
40.
41.

Combining phage display and molecular modeling to map the epitope of a neutralizing antitoxin antibody.

Demangel C, Maroun RC, Rouyre S, Bon C, Mazié JC, Choumet V.

Eur J Biochem. 2000 Apr;267(8):2345-53.

42.

Neutralizing human anti crotoxin scFv isolated from a nonimmunized phage library.

Cardoso DF, Nato F, England P, Ferreira ML, Vaughan TJ, Mota I, Mazie JC, Choumet V, Lafaye P.

Scand J Immunol. 2000 Apr;51(4):337-44.

44.

Molecular mimicry between a monoclonal antibody and one subunit of crotoxin, a heterodimeric phospholipase A2 neurotoxin.

Choumet V, Lafaye P, Demangel C, Bon C, Mazié JC.

Biol Chem. 1999 May;380(5):561-8.

PMID:
10384962
45.
46.
47.

Absorption and elimination of viper venom after antivenom administration.

Rivière G, Choumet V, Saliou B, Debray M, Bon C.

J Pharmacol Exp Ther. 1998 May;285(2):490-5.

PMID:
9580588
48.

Trimeresurus stejnegeri snake venom plasminogen activator. Site-directed mutagenesis and molecular modeling.

Zhang Y, Wisner A, Maroun RC, Choumet V, Xiong Y, Bon C.

J Biol Chem. 1997 Aug 15;272(33):20531-7.

49.

Biologically active human anti-crotoxin scFv isolated from a semi-synthetic phage library.

Lafaye P, Choumet V, Demangel C, Bon C, Mazié JC.

Immunotechnology. 1997 Jun;3(2):117-25.

PMID:
9237096
50.

Effect of antivenom on venom pharmacokinetics in experimentally envenomed rabbits: toward an optimization of antivenom therapy.

Rivière G, Choumet V, Audebert F, Sabouraud A, Debray M, Scherrmann JM, Bon C.

J Pharmacol Exp Ther. 1997 Apr;281(1):1-8.

PMID:
9103473

Supplemental Content

Loading ...
Support Center